Dyadic International DYAI
NASDAQ DYAI
$0.69 -0.01 (-1.43%)
At close: Aug 21, 2026 · 4:00 PM EDT

Dyadic International (DYAI) Prepaid Assets (2017 - 2026)

Dyadic International (DYAI) posted Prepaid Assets of $174238.0 for Q1 2026, down 20.46% sequentially from $219067.0 in Q4 2025, and down 17.37% YoY from $210867.0 in Q1 2025.

Dyadic International (DYAI) Prepaid Assets (2017 - 2026) Analysis & Trends

Dyadic International has reported Prepaid Assets for 10 years, with the latest figure at $174238.0 in Q1 2026.

  • Quarterly Prepaid Assets fell 17.37% year-over-year to $174238.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $174238.0 (down 17.37% YoY) and the FY2025 annual result came in at $219067.0, up 86.34% from the prior year.
  • Prepaid Assets fell to $174238.0 in Q1 2026 per DYAI's latest filing, from $219067.0 in the prior quarter.
  • Over five years, Prepaid Assets peaked at $148.7 million in Q1 2022 and troughed at $80.0 in Q1 2023.
  • A 5-year average of $8.9 million and a median of $174238.0 in 2026 frame the typical range for Prepaid Assets.
  • The sharpest annual moves came in 2022 and 2023: Prepaid Assets jumped 18271890.17% in 2022, then plunged 100.0% in 2023.
  • Over 5 years, Prepaid Assets stood at $124273.0 in 2022, then surged by 163.75% to $327775.0 in 2023, then tumbled by 64.13% to $117560.0 in 2024, then surged by 86.34% to $219067.0 in 2025, then decreased by 20.46% to $174238.0 in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $174238.0, $219067.0, and $339943.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Dyadic International 19.98 Mn 19.98 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 174,238.00
Dec 31, 2025 219,067.00
Sep 30, 2025 339,943.00
Jun 30, 2025 84,984.00
Mar 31, 2025 210,867.00
Dec 31, 2024 117,560.00
Sep 30, 2024 374,209.00
Jun 30, 2024 126,720.00
Mar 31, 2024 242,131.00
Dec 31, 2023 327,775.00
Sep 30, 2023 335.00
Jun 30, 2023 93,865.00
Mar 31, 2023 80.00
Dec 31, 2022 124,273.00
Sep 30, 2022 448,208.00
Jun 30, 2022 285.00
Mar 31, 2022 148.73 Mn
Dec 31, 2021 3,279.00
Sep 30, 2021 569,965.00
Jun 30, 2021 100,888.00